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Abstract
Because VEGFA has been implicated in follicle development, the objective of this study
was to determine the effects of granulosa- and germ cell-specific VEGFA loss on ovarian
morphogenesis, function, and female fertility. pDmrt1-Cremice were mated to floxed
VEGFA mice to develop granulosa-/germ cell-specific knockouts (pDmrt1-Cre;Vegfa-/-).
The time from mating to first parturition was increased when pDmrt1-Cre;Vegfa-/- females
were mated to control males (P = 0.0008) and tended to be longer for heterozygous females
(P< 0.07). Litter size was reduced for pDmrt1-Cre;Vegfa-/- females (P< 0.007). The time
between the first and second parturitions was also increased for heterozygous females
(P< 0.04) and tended to be increased for pDmrt1-Cre;Vegfa-/- females (P< 0.07). pDmrt1-
Cre;Vegfa-/- females had smaller ovaries (P< 0.04), reduced plasma estradiol (P< 0.007),
fewer developing follicles (P< 0.008) and tended to have fewer corpora lutea (P< 0.08).
Expression of Igf1r was reduced (P< 0.05); expression of Foxo3a tended to be increased
(P< 0.06); and both Fshr (P< 0.1) and Sirt6 tended to be reduced (P< 0.06) in pDmrt1-
Cre;Vegfa-/- ovaries. To compare VEGFA knockouts, we generated Amhr2-Cre;Vegfa-/-
mice that required more time from mating to first parturition (P< 0.003) with variable ovarian
size. Both lines had more apoptotic granulosa cells, and vascular staining did not appear
different. Taken together these data indicate that the loss of all VEGFA isoforms in granu-
losa/germ cells (proangiogenic and antiangiogenic) causes subfertility by arresting follicular
development, resulting in reduced ovulation rate and fewer pups per litter.
PLOS ONE | DOI:10.1371/journal.pone.0116332 February 6, 2015 1 / 20
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Introduction
Vascular endothelial growth factor A (VEGFA) is one of the key factors regulating angiogenesis
in the ovary [1]. VEGFA stimulates neovascularization, vascular permeability, acts as a survival
factor and can also stimulate proliferation of vascular and nonvascular cells [2–4]. An in situ
study showed the in vivo expression of VEGFA in different cell types including theca, cumulus,
granulosa and luteal cells in the mouse ovary [5]. Our laboratory has demonstrated that VEGFA
and its receptors are localized to pre-granulosa and granulosa cells of all follicle stages and to
theca cells and oocytes of advanced-stage follicles in the rat [6]. TheVegfa gene can be alternative-
ly spliced to produce angiogenic or antiangiogenic isoforms which have divergent functions from
one another: angiogenic isoforms promote vascular development while antiangiogenic isoforms
inhibit vascular development [6,7]. To initiate biological effects, VEGFA binds two related tyro-
sine kinase receptors: FMS-like tyrosine kinase 1 (FLT1, also known as VEGFR1) and kinase in-
sert domain receptor (KDR, also known as VEGFR2 and FLK1). The primary receptor is KDR
[8]. KDR is the major mediator of the mitogenic, angiogenic and permeability enhancing effects
of VEGFA. KDR is also involved in mediating endothelial cell proliferation, survival and vascular
permeability, whereas FLT1 may be inhibitory by sequestering VEGFA, and preventing its inter-
action with KDR [9]. Roberts et al. reported ovarian administration of antibodies to KDR resulted
in significant depletion of primordial follicle numbers, whereas anti-FLT1 antibodies did not
[10]. Thus, it appears that KDR is critical for follicle progression.
Independent of its angiogenic effects, VEGFA may also be important in the regulation of
follicle growth with direct effects on granulosa cells. While rat ovaries treated with VEGFA re-
ceptor-tyrosine kinase inhibitor had vascular development reduced by 94%, there were more
primordial follicles and fewer early primary, transitional, and secondary follicles compared to
controls suggesting a block in follicle progression [6]. This study demonstrated a novel role for
VEGFA in the recruitment of primordial follicles into the growing follicle pool, as well as being
a potential survival factor for primary and later-stage follicles through vascular-dependent and
vascular-independent mechanisms [6]. Further studies from our laboratory demonstrated that
treatment with proangiogenic isoform VEGFA_164 or neutralization of antiangiogenic
VEGFA isoforms enhanced vascular and follicular development in perinatal rat ovaries [7].
These results suggest that VEGFA proangiogenic isoforms stimulate follicle progression and
antiangiogenic isoforms inhibit or arrest follicle development [7]. Furthermore, our laboratory
has demonstrated that inhibition of antiangiogenic isoforms stimulates progression of follicles
to later stages of development providing further support that their normal function is to inhibit
folliculogenesis. Antiangiogenic isoforms were localized to granulosa and theca cells of all
stages of follicles in rats [7]. KDR-LacZ-positive staining in the oocytes of secondary follicles in
mice further suggests a role of VEGFA directly on oocyte development [11].
Thus, in the current study, we hypothesized that production of VEGFA isoforms (both pro
and antiangiogenic) by granulosa cells is critical for normal ovarian morphogenesis and func-
tion. Therefore, the objective of the present study was to determine the in vivo effects of granu-
losa (pDmrt1 and Amhr2) and potentially germ cell- (pDmrt1) specific VEGFA loss on ovarian
function and morphogenesis through conditional knockout mice in which Vegfa isoforms are
eliminated via either the pDmrt1 or Amhr2 promoter.
Materials and Methods
Animals
Granulosa and germ cell VEGFA knockout (KO) mice were generated by mating a Vegfa-floxed
mouse line [12] with porcine doublesex and mab-3 related transcription factor 1 (DMRT1)
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promoter (pDMRT1)-Cre mice [13]. HomozygousVegfa-floxed mice were mated to mice whose
genomic DNA genotyped positively for the pDmrt-1-Cre allele. Mating these parental lines re-
sulted in F1 progeny, and heterozygous mice from the F1 generation were then mated back to the
homozygousVegfa floxed founders to generate the F2 population. Control and homozygous
knockout female mice were generated from the F2 generation. We used Cre-negative Vegfa-/- or
Vegfa+/-mice as controls and Cre-positive Vegfa-/-mice as knockouts (KOs) (pDmrt1-Cre;
Vegfa-/-) or Cre-positive Vegfa+/- as heterozygotes (Het). Dmrt1 is expressed in the indifferent
mouse gonad at E10.5 in precursor cells that differentiate into Sertoli and granulosa cells [14]. By
E13.5, expression is no longer detectable in granulosa cells but is still present within oocytes until
E15.5 [14,15]. The pDmrt1 gene is expressed similarly to mouseDmrt1, as detected by reverse
transcriptase (RT)-PCR in developing ovaries, making it a useful means to eliminate Vegfa in
granulosa and germ cells [13]. In our pDmrt1-Cre;Vegfa-/-mouse, Cre recombinase activity is
driven by the pDmrt1 promoter which excises exon 3 of the Vegfa gene. Exon 3 is present in both
proangiogenic and antiangiogenic isoforms; thus, excision results in a reduction in all Vegfa iso-
forms where pDmrt1 is expressed (S1 Fig.). Ovaries plus oviducts, uteri, kidneys, and adrenals
were collected from 8-month-old female mice and weighed in addition to measuring total body
weight (n = 11 controls, n = 10 KO). Females were collected in estrus.
Similarly, we generated a transgenic mouse line by crossing the same floxed Vegfamice with
mice expressing Amhr2-Cre. Expression of the Amhr2-Cre transgene was detected as early as
12.5 dpc and continued through adulthood in pre-granulosa cells, granulosa cells and the fe-
male reproductive tract [16]. These mice were harvested at approximately 3-months-of-age,
earlier than collection of the Vegfa x pDmrt1-Cre animals (8 months). Reproductive potential
of the 8-month-old control animals was not impaired. The mice were harvested at different
ages in an attempt to compare reproductive phenotypes resultant from similar cell-specific
elimination of VEGFA both early and late in reproductive life.
All animal protocols were approved by the University of Nebraska Institutional Animal
Care and Use Committee (IACUC) in accordance with the National Institutes of Health Guide
for the Care and Use of Laboratory Animals. All animal models were procured from collaborat-
ing investigators with verbal or written MTA agreements. Thus, the corresponding author does
not have rights to freely distribute these mouse lines.
Genotyping
Genomic DNA was extracted from tail samples according to previously reported methods [17].
RNA was extracted from whole ovaries and reverse transcribed to cDNA to be tested for Cre
expression at the level of the gonad. Animals were removed from analysis if results differed
from genomic DNA genotyping. Primer sequences are supplied in Table 1.
Fertility Trials
Cyclic female mice were paired with control males when they were approximately 2–4 months-
of-age and remained together until they were six to eight months-of-age for both pDmrt1-Cre;
Vegfa-/- and Amhr2-Cre;Vegfa-/- mice. Control, Het and KO females were all paired with con-
trol males of proven fertility. The time from when males and females were placed together in
cages to the time of parturition was measured in days. We also determined the number of pups
per litter. Het females were removed from the Vegfa x Amhr2-Cre analysis due to ectopic
Cre expression.
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Fixation, Embedding, Staining, and Immunohistochemistry (IHC)
Ovaries were fixed at room temperature in Bouin’s solution, embedded in paraffin and sec-
tioned at 5 μm according to standard procedures [6]. The rabbit polyclonal IgG VEGFA prima-
ry antibody was raised against a peptide corresponding to amino acids 1–140 of human
VEGFA (catalog number: sc-507, Santa Cruz Biotechnology, Santa Cruz, CA). As a pan-anti-
body, it targeted both proangiogenic and antiangiogenic isoforms to confirm presence of
VEGFA isoforms in KO and control mouse ovaries. The antibody was diluted 1:100 in 10%
normal goat serum (NGS). As a negative control, serial sections were processed without prima-
ry antibody. Biotinylated goat anti-rabbit secondary antibodies were diluted 1:300 in 10% NGS
and were used with each primary antibody in this study (catalog number: BA-1000, Vector
Laboratories, Burlingame, CA). The secondary antibody was detected using aminoethyl carba-
zole (AEC) chromagen substrate solution (Invitrogen, Carlsbad, CA). Similar immunohis-
tochemistry protocols were used for additional primary antibodies. The cytochrome P450,
family 11, subfamily a, polypeptide 1 (CYP11A1) primary antibody (catalog number: ab78416;
Abcam, Cambridge, Mass., USA) was diluted 1:200 in 10% normal goat serum in PBS) and was
used to quantify the number of corpora lutea present.
Counts of Follicles and Corpora Lutea
In order to determine the number of follicles per ovary, three images per ovary were counted
by two technicians whose counts were averaged, and means were compared between Vegfa x
pDmrt1-Cre control (n = 8) and KO (n = 9) ovaries as well as for Vegfa x Amhr2-Cre control
(n = 4) and KO (n = 5) ovaries. One image was taken of the same ovary sectioned at representa-
tive depths- the most proximal and distal sections as well as the centermost section. Follicles
were staged according to previously reported methods [6,7]. Stage 0 or primordial follicles
Table 1. Sequences for primers used to conduct conventional and quantitative PCR.
PCR Gene Sequence Accession Number
Conventional pDmrt1(forward) 5’-AGCAGAGGCTTCCTTCGACTT-3’ AF216651
Cre (reverse) 5’-AGTGAACGAACCTGGTCGAAA-3’
muVEGF419.F 5’-TCCGTACGACGCATTTCTAG-3’
muVEGF567.R 5’-CCTGGCCCTCAAGTACACCTT-3’
qPCR Foxo3a 5’-GCAAAGCAGACCCTCAAACTG-3’ NM_019740
5’-TGAGAGCAGATTTGGCAAAGG-3’
Amh 5’-TCCTACATCTGGCTGAAGTGATATG-3’ NM_007445
5’-CAGGTGGAGGCTCTTGGAACT-3’
Gdf9 5’-GCCGGGCAAGTACAGCC-3’ NM_008110
5’-TTTGTAAGCGATGGAGCCG-3’
Igf1r 5’-CAGATGGCTGGAGAGATTGCA-3’ NM_010513.2
5’-GTGGACGAACTTGTTGGCATT-3’
Fshr 5’-TCCGCAGGGACTTCTTCGT NM_013523.3
5’-AATCTGGGCTTGCACCTCAT
Bmp2 5’-TGTCCCCAGTGACGAGTTTCT-3’ NM_007553.3
5’-CCTGTATCTGTTCCCGGAAGAT-3’
Sirt1 5’-AAACCTCCACGCCCACAA-3’ NM_019812.2
5’-GAAGAGGTGTTGGTGGCAACTC-3’
Sirt6 5’-AGCCCCCCGTGCATCT-3’ NM_181586.3
5’-TGTTGGGCTTGGACTTATACGA-3’
doi:10.1371/journal.pone.0116332.t001
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consisted of an oocyte surrounded by a single layer of squamous granulosa cells. Stages 1–5
were grouped together as developing follicles. Stage 1 follicles were characterized by an oocyte
surrounded by a single layer of a mixture of squamous and cuboidal granulosa cells. To be clas-
sified as Stage 2, all granulosa cells were cuboidal. Two or more layers of squamous granulosa
cells had to present to be considered a Stage 3 follicle. Stage 4 follicles had a visible theca cell
layer as well as an antrum. Stage 5 follicles had a large antrum and appeared to be ready to ovu-
late. Corpora lutea (CL) were evidenced by positive staining for the steroidogenic enzyme
CYP11A1. The number of CL on one ovary per animal was counted and compared between
Vegfa x pDmrt1-Cre control (n = 8) and KO ovaries (n = 9). Follicles were counted at
200x magnification.
Quantitative RT- PCR (qPCR)
One ovary was collected from each animal for RNA extraction, reverse transcription to cDNA
and quantitative Real-Time PCR (qPCR) analysis according to previous protocols [6,17]. Prim-
ers and probes were designed with Primer Express 3.0 software (Applied Biosystems) and syn-
thesized at Integrated DNA Technologies, Inc. (Coralville, IA). Amplification of genes that
required SYBR Green to measure quantification was also plotted on a dissociation curve to en-
sure primer dimerization did not occur. We designed probes for two genes: BCL2-associated X
protein (Bax) and B cell leukemia/lymphoma 2 (Bcl2). Primer and probe sequences for each
gene are found in Table 1. Primers were designed for Foxo3a, Igf1r, Fshr, Bmp2, Sirt1, Sirt6,
Amh, and Gdf9. Messenger RNA abundance was normalized to expression of the housekeeping
gene, glyceraldehyde-3-phosphate dehydrogenase (Gapdh) and represented as a fold change
relative to the mean control value (set at a value of 1). The expression of Gapdh was determined
using a VIC probe and primer kit (Taqman Rodent GapDH Control Reagents; Applied Biosys-
tems; Catalog #4308313). Values were expressed as means±SEM.
Hormone Assays
Trunk blood was collected at the time of euthanasia and prepared for ELISA according to rou-
tine methods [17]. Plasma estradiol concentrations were determined by ELISA kit (Catalog
#1920, Alpha Diagnostics International Inc., San Antonio, TX). Samples remained undiluted
and were run according to the manufacture’s direction. All unknown values were plotted
against a standard curve. Assay sensitivity was 10 pg/ml. The progesterone concentrations
were determined by ELISA kit (Catalog #1860, Alpha Diagnostics International Inc.). Assay
sensitivity was 0.2 ng/ml. Testosterone concentrations were determined by a testosterone
ELISA kit (catalog number: 1880; Alpha Diagnostics International Inc., San Antonio, TX) [18].
Assay sensitivity was 0.125 ng/ml.
Immunofluorescence
Ovaries were processed for immunofluorescence as described for IHC and according to previ-
ous methods in our laboratory [17] with a rabbit polyclonal primary antibody to cleaved Cas-
pase 3 (CASP3; Asp 175; catalog number: #9661; Cell Signaling, Danvers, MA). An anti-rabbit
FITC secondary antibody (Alexa Fluor 488; catalog number: #4412S; Cell Signaling) was added
to bind the cleaved CASP3 primary antibody, and it was diluted 1:1000 in 3% bovine serum al-
bumin (BSA) in PBS-Tween. A goat antibody to VE-CADHERIN (catalog number: #sc-6458;
Santa Cruz Biotechnology, Inc.) was also used to visualize vasculature. To detect expression of
VE-cadherin, we used an anti-goat Texas Red secondary antibody (Alexa Fluor 594; catalog
number: #A-21223; Invitrogen/Life Technologies, Grand Island, NY). We also stained ovaries
from Vegfa x Amhr2-Cre control and KO (Amhr2-Cre;Vegfa-/-) females to increase the number
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of representative images since they have a similar mechanism of eliminating VEGFA. Two im-
ages were taken at 200x of both control (n = 3) and KO (n = 4) ovaries. Both primary antibod-
ies were diluted 1:50 in 3% BSA (catalog number: #A3311; Sigma-Aldrich Corp., St. Louis,
MO) in PBST, and both secondary antibodies were diluted 1:1000 in 3% BSA.
Statistical Analysis
Fertility data were analyzed by one-way ANOVA followed by t-test using SAS software (SAS
Institute, Cary, NC). All other data were analyzed using the Dunnett’s procedure in JMP (SAS
Institute). Differences in data were considered statistically significant when P< 0.05. Data
were considered tending to be different if 0.05> P< 0.1. All treatments were compared rela-
tive to controls. Gene expression data were tested for normality, and data that were not nor-
mally distributed were square rooted using SAS. Means reflect the original data, but P-values
are representative of the Dunnett’s test following transformation.
Results
pDmrt1-Cre;Vegfa-/-mice were subfertile and had reduced ovarian
weight
Immunohistochemistry with a pan-VEGFA antibody was performed to confirm the deletion of
both pro- and antiangiogenic isoforms of VEGFA in KO ovaries at 8 months-of-age. The inten-
sity of VEGFA-positive staining was dramatically reduced in ovaries taken from pDmrt1-Cre;
Vegfa-/- females (Fig. 1B) compared to controls (Fig. 1A). Sections processed without primary
antibody did not stain and served as negative controls (Fig. 1C).
Mice were placed in mating pairs as follows: 1) control females with control males (Contl x
Contl, n = 12), 2) heterozygous females with control males (Het x Cont, n = 10), and 3) KO fe-
males with control males (KO x Contl, n = 5). Het x Cont mating pairs from Vegfa x pDmrt1-Cre
mice tended to take 10 days longer to get pregnant during the first mating to parturition interval
(P< 0.07), and KO females took significantly longer to get pregnant when mated to control
males (P = 0.0008) compared to Cont x Cont pairs (Fig. 1D). While there were no differences in
the number of pups born in the first litter for Het x Control (P = 0.32), there were fewer pups
born to KO x Cont mating pairs (P< 0.007) compared to Cont x Cont matings (Fig. 1E). Finally
as seen in Fig. 1F, the number of days between the first and second parturitions for Het x Control
pairs was increased (P< 0.04) and tended to be increased for KO x Cont mating pairs (P< 0.07)
compared to the length for Cont x Cont mating pairs. Females were collected at the end of the
fertility trial, and the combined weight of ovaries and oviducts from pDmrt1-Cre;Vegfa-/- females
was significantly decreased compared to control females (P< 0.04, Fig. 1G). Control mice at the
end of the fertility trial were still reproductively viable while the KOmice were less so, as indicat-
ed by the preceding data.
Plasma estradiol concentrations were reduced in pDmrt1-Cre;
Vegfa-/-mice
Plasma 17β-estradiol in blood collected at the end of the fertility trial was reduced by almost
half in pDmrt1-Cre;Vegfa-/- females (P< 0.007) compared to control females (Fig. 2A). There
was no significant difference in plasma progesterone concentrations between the pDmrt1-Cre;
Vegfa-/- (P = 0.77) and control females (Fig. 2B). There was also no difference in plasma testos-
terone concentrations in pDmrt1-Cre;Vegfa-/- females (P = 0.26) compared to control females
(Fig. 2C).
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Fig 1. Immunohistochemistry with panVEGFA antibody to confirm VEGFA knockdown via pDmrt1-
Cre and female fertility: 200x magnification in a pDmrt1-Cre;Vegfa-/- ovary (B) and a control ovary (A).
Negative control ovaries were processed without primary antibody (C). Females are named first in each
fertility trial pairing (Control, Het, KO) for Vegfa x pDmrt1-Cre and were broken into mating to first parturition
(D), the number of pups born at the first parturition (E) and the number of days from the first parturition to the
second (F). For the Control x Control, Het x Control, and KO x Control pairs in both (D) and (E), n = 12, 10,
and 5, respectively. For the Control x Control, Het x Control, and KO x Control pairs in (F), n = 4, 4, and 5,
respectively. Ovarian plus oviductal weight (g) is presented in KO vs control females (G), and n = 10 and 11,
respectively. Results represented by either different letters or a * were significant when P< 0.05, and a †
denoted data that tended to be significant (0.05< P< 0.1).
doi:10.1371/journal.pone.0116332.g001
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There were fewer developing follicles and a tendency for a reduction in
CL number in pDmrt1-Cre;Vegfa-/- ovaries
While the number of primordial follicles (Stage 0) was not different per ovary between
pDmrt1-Cre;Vegfa-/- and control females, pDmrt1-Cre;Vegfa-/- females had half as many
developing follicles (Stages 1–5) per ovary (P< 0.008) as control females (Fig. 3E). Fewer later
stage follicles can be seen on the accompanying 100x images of a pDmrt1-Cre;Vegfa-/- ovary
(Fig. 3B) compared to a control ovary (Fig. 3A), and the pDmrt1-Cre;Vegfa-/- ovaries appear
smaller than controls. In addition, the number of CL per ovary on pDmrt1-Cre;Vegfa-/- ovaries
(P< 0.08) tended to be reduced compared to control mice (Fig. 3F). At 200x, the morphology
of two CL in a representative KO ovary appeared to have fewer and less densely compacted
luteal cells compared to a control (Fig. 3C, D).
pDmrt1-Cre;Vegfa-/- female ovaries had reduced Igf1r, Fshr, Sirt6
andFoxo3amRNA at 8 months of age
Quantitative real-time PCR analysis was performed on one whole ovary from each animal to
determine the expression of genes known to regulate growth and follicular development. Mes-
senger RNA abundance for insulin-like growth factor 1 receptor (Igfr1) was significantly re-
duced 3.5-fold in ovaries lacking VEGFA isoforms (P< 0.05) compared to controls (Fig. 4A)
at 8 months of age. Its ligand, IGF1 is important for ovarian function and proliferation of
granulosa cells [19]. Forkhead boxo3a (FOXO3A) is a transcription factor that inhibits the acti-
vation of primordial follicles. Messenger RNA abundance for Foxo3a tended to be increased
4.8-fold in pDmrt1-Cre;Vegfa-/- ovaries (P< 0.06) compared to that of controls (Fig. 4B). Pri-
mordial follicles numbers were a maximum of one or two per section; thus, a difference was
Fig 2. Plasma hormone concentrations in Vegfa x pDmrt1-Cre females. Concentrations of plasma E2
(A), progesterone (B) and testosterone (C) in KO (n = 7–10) compared to controls (n = 9–11). Results were
significant when P< 0.05 and were represented with a *.
doi:10.1371/journal.pone.0116332.g002
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not detectable statistically. Follicle stimulating hormone receptor (Fshr) mRNA abundance
tended to be reduced 3-fold in pDmrt1-Cre;Vegfa-/- ovaries (P< 0.1) compared to controls
(Fig. 4C). FSHR is the receptor for the gonadotropin, FSH, and would be indicative of FSH sig-
naling in the ovary. While expression of sirtuin 1 (Sirt1) did not differ between pDmrt1-Cre;
Vegfa-/- and control ovaries (Fig. 4E), sirtuin 6 (Sirt6) mRNA abundance tended to be reduced
6.5-fold in pDmrt1-Cre;Vegfa-/- ovaries (P< 0.06) compared to control ovaries (Fig. 4F). Sir-
tuins are ultimately important in maintenance following caloric restriction. FOXO3A is a sub-
strate for SIRT1, and deletion of SIRT1 results in female infertility [20–22]. There were no
differences in mRNA abundance of bone morphogenetic protein 2 (Bmp2), anti-Müllerian
Fig 3. pDmrt1-Cre;Vegfa-/- and control ovary histology.Hematoxylin-eosin staining of ovarian cross-
sections of 200x control (A), 200x control (C), 200x KO (B), and 200x KO (D). The 200x images depict varied
CL morphology between a control and KO. Some of the ovarian structures are labeled: corpus luteum (CL)
and the stage of follicle (1–4). The number of primordial follicles (stage 0) and developing follicles (stages
1–5) were counted and compared between controls (n = 8) and KO (n = 9) (E). The number of CL per ovarian
section was counted based on positive staining for CYP11A1 and compared between controls (n = 8) and KO
(n = 6) (F). Results were significant when P< 0.05 and were represented with a *, and a † denoted data that
tended to be significant (0.05< P< 0.1).
doi:10.1371/journal.pone.0116332.g003
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hormone (Amh), or growth differentiation factor 9 (Gdf9) between KO and control ovaries
(Fig. 4D, G-H) at 8 months of age. BMP family members have been shown to be regulators of
the FOXOs [23]. AMH is expressed in granulosa cells prior to their differentiation and until
Fig 4. Whole ovary mRNA abundance for Vegfa x pDmrt1-Cre female mice: Igf1r (A), Foxo3a (B), Fshr
(C), Bmp2 (D), Sirt1 (E), Sirt6 (F), Amh (G) andGdf9 (H).Mean KO values (n = 2–6) are represented as fold
changes ± SEM compared to control (n = 3–9) mean (set to 1). Results were significant when P< 0.05 and
were represented with a *, and a † denoted data that tended to be significant (0.05< P< 0.1).
doi:10.1371/journal.pone.0116332.g004
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follicles are at the early antral stage [24,25]. GDF9 is expressed by the oocyte, and when
knocked out, results in impaired follicular development [26,27].
VEGFA loss via the Amhr2-Cre promoter resulted in an increase in the
time from mating to first parturition (three-months-of-age) and increased
AmhmRNA abundance
We confirmed the effects on fertility by elimination of VEGFA in another mouse line, Vegfa x
Amhr2-Cre. These females were collected at 3-months-of-age, earlier than the Vegfa x Dmrt1-
Cre females (8 months). The same pan-VEGFA antibody was used to verify knockdown of
VEGFA in ovaries of Amhr2-Cre;Vegfa-/- mice (Fig. 5B) compared to controls (Fig. 5A). Sections
that were processed without primary antibody served as negative controls (Fig. 5C).
On average Amhr2-Cre;Vegfa-/- mice females took 35 days longer to get pregnant during
their first mating to control males (P< 0.003; n = 4) than control females mated to control
males in the Vegfa x Amhr2-Cremice (Fig. 5D) with no measurable change in litter size. Addi-
tionally, there was no difference in the combined ovarian and oviductal weight from Amhr2-Cre;
Vegfa-/- (P = 0.69) mice compared to controls (Fig. 5E) at 3 months-of-age unlike the 8-month-
old pDmrt1-Cre;Vegfa-/- females, suggesting that the loss of VEGFA isoforms may affect fertili-
ty in a progressive manner.
While there was no difference in follicle numbers on Amhr2-Cre;Vegfa-/- ovaries compared
to controls (Fig. 5F) as well as no differences in mRNA abundance of the genes that were statisti-
cally significant in pDmrt1-Cre;Vegfa-/- ovaries (S2 Fig.), Amh was increased 2-fold in Amhr2-
Cre;Vegfa-/- ovaries (P< 0.03) compared to controls (Fig. 5G).
Ovarian size was variable for Amhr2-Cre;Vegfa-/-mice
Ovarian size varied greatly in Amhr2-Cre;Vegfa-/- mice despite no differences in ovarian weight
or follicle number. Some of the Amhr2-Cre;Vegfa-/- mice KO ovaries were similar in size to
controls (Fig. 6A, B); however, some appeared greatly reduced in size (Fig. 6C). The variability
in ovarian size could be due to variability in the levels of Amhr2-Cre [28]. The variability in
ovarian size coordinated with estradiol concentrations in the plasma without overall statistical
significance: low estradiol concentrations were measured in females with smaller ovaries while
the high concentrations were measured in females with larger ovaries.
Cleaved Caspase 3-positive staining appeared more abundant in granulosa cells of
pDmrt1-Cre;Vegfa-/- and Amhr2-Cre;Vegfa-/- ovaries. Caspases are involved in apoptosis
[29]. Positive staining for cleaved caspase 3 (CASP3) did not appear to be present in control
ovaries (Fig. 7B-C, E-F). In both the pDmrt1-Cre;Vegfa-/- and the Amhr2-Cre;Vegfa-/- ovaries,
there was cleaved CASP3-positive staining in granulosa cells not seen in controls, suggestive of
granulosa cell apoptosis primarily seen in secondary follicles. Hematoxylin-eosin staining de-
picting the same fluorescently stained follicles is shown at 400x (Fig. 7A, D, G, J). While sec-
tions were not serial, the H-E sections were within 4–5 sections of the immunostained sections.
Follicles on ovaries from Amhr2-Cre;Vegfa-/- females exhibited granulosa cells with darker H-E
staining indicative of pyknosis.
VE-cadherin-positive immunofluorescence did not appear different
between control and pDmrt1-Cre;Vegfa-/- and Amhr2-Cre;Vegfa-/-
ovaries
Ovaries from both pDmrt1-Cre;Vegfa-/- and Amhr2-Cre;Vegfa-/- mice were immunostained
with an antibody to VE-cadherin, a known vascular marker. VE-cadherin-positive staining,
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Fig 5. Immunohistochemistry with panVEGFA antibody to confirm VEGFA knockdown via Amhr2-
Cre, female fertility and qPCR analysis: 200xmagnification in an Amhr2-Cre;Vegfa control ovary (A)
and an Amhr2-Cre;Vegfa-/- ovary (B). Negative control ovaries were processed without primary antibody
(C). For the Control x Control and KO x Control pairs in for mating to first parturition (D), n = 4. Ovarian plus
oviductal weight (mg) is presented in KO vs control females (E) while follicle counts are presented in (F) and
AmhmRNA is represented similarly (G), and n = 10 controls and 11 KO for each graph, respectively. Results
were significant when P< 0.05 and were represented with a *.
doi:10.1371/journal.pone.0116332.g005
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demonstrating the presence of vasculature was at similar intensities and appeared to stain
blood vessels similarly in both control and KO ovaries from both lines of mice Representative
sections of Amhr2-Cre;Vegfa-/- and respective control ovaries are depicted (Fig. 8A, B). Similar
results were seen in the testes of pDmrt1-Cre;Vegfa-/- males [17]. Negative controls had back-
ground reduced and were not treated with primary antibody (Fig. 8C).
Discussion
The findings generated from the current study demonstrated that loss of VEGFA in granulosa
(pDmrt1- and Amhr2-Cre) and germ cells (pDmrt1-Cre) resulted in subfertile females. While
VEGFA has been previously implicated in fertility, this is the first time conditional loss of both
pro- and antiangiogenic VEGFA isoforms has been accomplished within the granulosa cells of
the ovary. The loss of VEGFA resulted in females taking longer to get pregnant, giving birth to
fewer pups per litter, having reduced plasma estradiol, containing more apoptotic granulosa
cells, resulting in fewer developing follicles and a tendency to have fewer corpora lutea. Addi-
tionally, the subfertility phenotype was supported in Amhr2-Cre;Vegfa-/- ovaries (3 months of
age) and appeared more pronounced in the pDmrt1-Cre;Vegfa-/- mice which was presumably
due to the later age of these mice at collection (8 months of age); however, we cannot ignore that
the differences between the mouse lines could also be due to the different cell types suffering
VEGFA isoform loss. This is currently being investigated in our laboratory through a granulosa
cell-specific elimination of VEGFA. The phenotypes from both of these mouse lines support
earlier findings in our laboratory regarding the importance of VEGFA isoforms in follicle re-
cruitment and development [6,7]. Furthermore, in mice overexpressing antiangiogenic VEG-
FA165b that were collected between 2- and 4-months-of-age, there is a similar phenotype with
half the litter size, fewer mature follicles, and fewer CL [30]. Thus, eliminating all VEGFA iso-
forms or overexpression of VEGFA165b in granulosa cells appears to reduce female fertility.
Both pDmrt1-Cre;Vegfa-/- (8-months-old) and Amhr2-Cre;Vegfa-/- females (3-months-old)
were subfertile. The longer period leading to parturition in female KO mice compared to con-
trols suggested a decreased rate of ovulation in the female KO mice or ovulation of oocytes that
are not competent to be fertilized. Ha et al., showed that estrogen administration increases
ovarian VEGFA expression and suggested that VEGFA improves the number and quality of
oocytes [31]. In our study, the loss of VEGFA in pDmrt1-Cre;Vegfa-/- resulted in reduced estro-
gen in blood plasma which was presumably due to a reduced number of follicles developing.
As mentioned previously, ovarian weight and plasma estradiol concentrations had a positive
relationship in Vegfa x Amhr2-Cre females. The reduction in estrogen levels may also
Fig 6. Amhr2-Cre;Vegfa-/- and control ovary histology.Hematoxylin-eosin staining of Amhr2-Cre;Vegfa-/- ovaries of variable sizes (B, C) compared to a
control (A) at 100x magnification.
doi:10.1371/journal.pone.0116332.g006
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Fig 7. Morphology of stage 4 follicles by hematoxylin-eosin (H-E) staining and cleaved CASP3-positive staining of same follicles. H-E staining of
follicles is shown at 400x for controls (A, D) and KOs (G, J). Green cleaved CASP3-positive staining is shown in follicles at 400x in controls (B, E) and in KOs
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contribute to a reduction in the quality of oocytes. The aromatase knockout mouse, the estro-
gen β receptor knockout mouse, and the estrogen α receptor knockout mouse have demon-
strated that estrogen enhances the number of follicles progressing to the early antral stage
[32–35]. Furthermore, a positive relationship between VEGFA and E2 concentrations in gilt
follicular fluid suggests a possible cause-and-effect relationship [36] with VEGFA stimulating
estrogen production by increasing vascular permeability to cholesterol and increasing signal
transduction pathways activating enzymes that are critical for estrogen production. One study
showed that plasma 17β-estradiol concentration in rats treated with VEGFA120 and 164 were
significantly higher than that in the control rats, indicating that VEGFA120 and 164 may indi-
rectly stimulate the production of 17β-estradiol via granulosa cells [37].
In our study, plasma 17β-estradiol levels in the pDmrt1-Cre;Vegfa-/- were significantly lower
than that in the controls. Our results indicated that loss of VEGFA in granulosa cells inhibits
the production of 17β-estradiol in pDmrt1-Cre;Vegfa-/- and the granulosa cells from both
pDmrt1-Cre;Vegfa-/- and Amhr2-Cre;Vegfa-/- mice had increased staining for cleaved CASP3 as
well as an increased number of pyknotic nuclei in granulosa cells. Previous studies have dem-
onstrated that intrabursal injections of VEGFA trap (an inhibitor of VEGFA) resulted in re-
duced granulosa cell proliferation [38]. Thus, the in vivo phenotype of both of our KO mouse
lines supports a role for VEGFA in granulosa cell survival and in enhancing its ability to pro-
duce steroid hormones such as estradiol promoting the viability of follicle development
and progression.
McFee et al. previously demonstrated a role for VEGFA in primordial follicle activation,
maturation and survival [6]. Rat ovaries treated transiently with VEGFA_164 were composed
of fewer primordial follicles (stage 0) and more developing follicles (stages 1–4) than controls.
Ovaries treated with VEGFAxxxB antibody to neutralize all antiangiogenic isoforms had fewer
primordial and early primary follicles and more primary, transitional, and secondary follicles
compared to controls (7). These data indicate that VEGFA proangiogenic isoforms promote
follicle development, and in contrast, VEGFA antiangiogenic isoforms maintain primordial
follicles in an arrested state. Removal of VEGFA antiangiogenic isoforms allows for increased
progression of primordial follicles to the developing follicle pool [7]. Given previous findings
in our laboratory with transient treatments in culture, we suspect that the number of
(H, K). Cleaved CASP3-positive staining is shown in the same follicles but co-localized with DAPI at 400x in controls (C, F) and KOs (I,L). Negative controls
were processed without primary antibody (M). Black arrows point to pyknotic granulosa cells on H-E stained follicles while arrows point to cleaved CASP3-
positive granulosa cells.
doi:10.1371/journal.pone.0116332.g007
Fig 8. VE-cadherin-positive immunostaining in representative ovaries: Amhr2-Cre;Vegfa-/-KO ovaries (B) compared to controls from the same
mouse line (A) depicted at 200x magnification.White arrows denote blood vessels. Negative controls were processed without primary antibody (C).
doi:10.1371/journal.pone.0116332.g008
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primordial follicles is increased in the pDmrt1-Cre;Vegfa-/- females’ ovaries given the increase
in Foxo3amRNA even if differences were not detectable. At the same time, the differences may
not be statistically relevant given the apparent increase in cleaved CASP3-positive granulosa
cells, suggesting that some of the follicles that did advance in the pDmrt1-Cre;Vegfa-/- females
regressed prematurely. VEGFA165 also promoted the primary-to-secondary follicle transition
in bovine ovaries activated in vitro [39]. Furthermore, in vivo studies showed that inhibition of
VEGFA and KDR can inhibit follicular development or prevent ovulation [40,41]. Thus, in ad-
dition to follicular development VEGFA also appears to affect ovulation in later stage
preovulatory follicles.
In our study, ovarian weight in KO mice was reduced compared to that of control females.
This suggests that loss of VEGFA in granulosa and germ cells within mouse ovaries affects
ovarian size through reductions of follicle development and/or maturation. Another reason for
the reduced ovarian size in the KO females is due to the reduced number of CL despite no
change in progesterone. An in vivo study showed that the VEGFA angiogenic isoform promot-
ed ovarian follicular angiogenesis leading to stimulatory effects on subsequent follicular devel-
opment and numbers of oocytes ovulated in mature cycling rats [37]. Furthermore, inhibition
of VEGFA and KDR suppressed follicular development and ovulation [40,41]. Presumably, the
fewer CL in ovaries of pDmrt1-Cre;Vegfa-/- females may be caused by fewer antral follicles and
subsequently fewer ovulations in those mice, ultimately resulting in smaller ovaries and a
marked reduction in litter size compared to controls.
Another plausible theory for the reduction in ovarian weight in the KO females would be
that loss of VEGFA in granulosa cells may reduce angiogenesis, the blood supply for oxygen,
nutrients and influence the growth of the ovary and follicle maturation. However, this model
utilizes the Cre-lox approach to eliminate VEGFA from granulosa cells and oocytes, cells that
are avascular. Still, we investigated ovarian vasculature via immunostaining. Ovarian vascula-
ture in two similar KO mouse models (pDmrt1-Cre;Vegfa-/- and Amhr2-Cre;Vegfa-/-) did not
appear different from controls based on positive staining of VE-cadherin. Similarly, we did not
see effects in pDmrt1-Cre;Vegfa-/- male mice where VEGFA was eliminated in Sertoli and germ
cells [17].
To further characterize the reproductive phenotypes caused by VEGFA loss, we performed
qPCR analysis of genes that are known regulators of ovarian function. FOXO3A is a key oocyte
factor critical for suppressing primordial follicle activation [22]. Liu et al. reported that loss of
Foxo3a expression in mice results in premature follicle activation [42]. Foxo3amRNA was 4.8-
fold higher in KO ovaries than controls, suggestive of potential suppression of follicle progres-
sion in these ovaries. Moreover, members of the FOXO family have been shown to regulate
many vital cellular processes including metabolism [43,44]. Interestingly, it has been suggested
that insulin and IGF-1 signaling inactivate the FOXOs in other tissues [45]. FOXO transcrip-
tion factors are further implicated in this study by the 3.5-fold decrease in Igf1rmRNA in the
ovaries of the females following VEGFA loss. Additionally, IGF1R expression has been demon-
strated to be highest in large luteal cells of the bovine CL; thus, the disruption in follicle pro-
gression in our mice and subsequent reduction in CL number could be a result of the reduction
in Igf1r [46] since whole ovaries were analyzed. It has also been demonstrated that FSH and
IGF1 work synergistically in human, mouse and rat granulosa cells to stimulate AKT-depen-
dent granulosa cell proliferation [47]. These findings, together with our observed reductions in
mRNA abundance for Igf1r and Fshr, further support the apoptotic granulosa cells seen in ova-
ries of both pDmrt1-Cre;Vegfa-/- and Amhr2-Cre;Vegfa-/- mice as well as the reduction in litter
size of pDmrt1-Cre;Vegfa-/- females. Also striking is the 6.5-fold reduction in Sirt6 because of
the direct relationship of sirtuins with FOXO3A and infertility [48]. It has been posited that
AMH increases VEGFA; thus, the increase in AmhmRNA abundance in Amhr2-Cre;Vegfa-/-
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ovaries could be to atone for the elimination of VEGFA in follicular cells [49]. While we did
not detect differences in follicle counts, ovarian weight or plasma estradiol concentrations
when Vegfa was lost via the Amhr2-Cre promoter, we did see prolonged first mating period
and variability in ovarian size as well as the presence of apoptotic granulosa cells. Thus, the in-
crease in AmhmRNA could also be explained to be a block against the follicle’s sensitivity to
FSH [49]. Again, these mice were harvested at 3-months-of-age, and the phenotype did not ap-
pear as progressed as in the pDmrt1-Cre;Vegfa-/- mice at 8 months of age.
In conclusion, we demonstrated that removal of VEGFA angiogenic and antiangiogenic iso-
forms in granulosa cells via the pDmrt1 promoter resulted in reduced ovarian weight, fewer CL
and reduced estrogen concentrations (by 50%). Furthermore, the time period between mating
and parturition was longer in both pDmrt1-Cre;Vegfa-/- and Amhr2-Cre;Vegfa-/- mice than in
controls, and pDmrt1-Cre;Vegfa-/- females gave birth to fewer pups. Additionally, pDmrt1-Cre;
Vegfa-/- females had increased Foxo3a, reduced Igf1r, Fshr, and Sirt6mRNA levels. These data
are suggestive of primordial follicle arrest and reduced proliferation, further implicated by in-
creased apoptotic granulosa cells as indicated by immunofluorescence that was observed in
both pDmrt1-Cre;Vegfa-/- and Amhr2-Cre;Vegfa-/- mice. The present data suggest that VEGFA
is necessary for normal follicular development, estrogen synthesis, and ovulation. These reduc-
tions in ovarian function likely contributed to the increased interval from mating to parturition
in both pDmrt1-Cre;Vegfa-/- and Amhr2-Cre;Vegfa-/- mice. Ultimately, these data support the
concept that the loss of VEGFA results in subfertility by limiting follicle progression and subse-
quent ovulation and that this phenotype appears to be more dramatic as the female progress in
age as demonstrated by the 3-month Amhr2-Cre;Vegfa-/- and 8-month pDmrt1-Cre;Vegfa-/-
phenotypes or due to differences in cell-specific VEGFA loss.
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S1 Fig. Schematic depicting conditional elimination of VEGFA isoforms occurs in granu-
losa cells.
(PPTX)
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